131 related articles for article (PubMed ID: 10517563)
1. Long-term stability of abused drugs and antiabuse chemotherapeutical agents stored at -20 degrees C.
Moody DE; Monti KM; Spanbauer AC
J Anal Toxicol; 1999 Oct; 23(6):535-40. PubMed ID: 10517563
[TBL] [Abstract][Full Text] [Related]
2. Stability of drugs of abuse in urine samples stored at -20 degrees C.
Dugan S; Bogema S; Schwartz RW; Lappas NT
J Anal Toxicol; 1994; 18(7):391-6. PubMed ID: 7861752
[TBL] [Abstract][Full Text] [Related]
3. Stability of Drugs of Abuse in Urine Samples at Room Temperature by Use of a Salts Mixture.
Pellegrini M; Graziano S; Mastrobattista L; Minutillo A; Busardo FP; Scarsella G
Curr Pharm Biotechnol; 2017; 18(10):815-820. PubMed ID: 29231136
[TBL] [Abstract][Full Text] [Related]
4. Plasma and urine profiles of Delta9-tetrahydrocannabinol and its metabolites 11-hydroxy-Delta9-tetrahydrocannabinol and 11-nor-9-carboxy-Delta9-tetrahydrocannabinol after cannabis smoking by male volunteers to estimate recent consumption by athletes.
Brenneisen R; Meyer P; Chtioui H; Saugy M; Kamber M
Anal Bioanal Chem; 2010 Apr; 396(7):2493-502. PubMed ID: 20112012
[TBL] [Abstract][Full Text] [Related]
5. Determination of l-alpha-acetylmethadol (LAAM), norLAAM, and dinorLAAM in clinical and in vitro samples using liquid chromatography with electrospray ionization and tandem mass spectrometry.
Huang W; Bemis PA; Slawson MH; Moody DE
J Pharm Sci; 2003 Jan; 92(1):10-20. PubMed ID: 12486677
[TBL] [Abstract][Full Text] [Related]
6. Simultaneous determination of delta9-tetrahydrocannabinol and 11-nor-9-carboxy-delta9-tetrahydrocannabinol in human plasma by solid-phase extraction and gas chromatography-negative ion chemical ionization-mass spectrometry.
Huang W; Moody DE; Andrenyak DM; Smith EK; Foltz RL; Huestis MA; Newton JF
J Anal Toxicol; 2001 Oct; 25(7):531-7. PubMed ID: 11599596
[TBL] [Abstract][Full Text] [Related]
7. Quantitative analysis of l-alpha-acetylmethadol, l-alpha-acetyl-N-normethadol, and l-alpha-acetyl-N,N-dinormethadol in human hair by positive ion chemical ionization mass spectrometry.
Wilkins DG; Valdez AS; Krueger GG; Rollins DE
J Anal Toxicol; 1997 Oct; 21(6):420-6. PubMed ID: 9323520
[TBL] [Abstract][Full Text] [Related]
8. Sweat testing in opioid users with a sweat patch.
Kintz P; Tracqui A; Mangin P; Edel Y
J Anal Toxicol; 1996 Oct; 20(6):393-7. PubMed ID: 8889674
[TBL] [Abstract][Full Text] [Related]
9. ONTRAK TESTCUP: a novel, on-site, multi-analyte screen for the detection of abused drugs.
Towt J; Tsai SC; Hernandez MR; Klimov AD; Kravec CV; Rouse SL; Subuhi HS; Twarowska B; Salamone SJ
J Anal Toxicol; 1995 Oct; 19(6):504-10. PubMed ID: 8926746
[TBL] [Abstract][Full Text] [Related]
10. Fast and highly selective LC-MS/MS screening for THC and 16 other abused drugs and metabolites in human hair to monitor patients for drug abuse.
Koster RA; Alffenaar JW; Greijdanus B; VanDernagel JE; Uges DR
Ther Drug Monit; 2014 Apr; 36(2):234-43. PubMed ID: 24071815
[TBL] [Abstract][Full Text] [Related]
11. A gas chromatographic-positive ion chemical ionization-mass spectrometric method for the determination of I-alpha-acetylmethadol (LAAM), norLAAM, and dinorLAAM in plasma, urine, and tissue.
Moody DE; Crouch DJ; Sakashita CO; Alburges ME; Minear K; Schulthies JE; Foltz RL
J Anal Toxicol; 1995 Oct; 19(6):343-51. PubMed ID: 8926727
[TBL] [Abstract][Full Text] [Related]
12. Prevalence and disposition of drugs of abuse and opioid treatment drugs in oral fluid.
Cone EJ; Clarke J; Tsanaclis L
J Anal Toxicol; 2007 Oct; 31(8):424-33. PubMed ID: 17988455
[TBL] [Abstract][Full Text] [Related]
13. Assessment of the ion-trap mass spectrometer for routine qualitative and quantitative analysis of drugs of abuse extracted from urine.
Vorce SP; Sklerov JH; Kalasinsky KS
J Anal Toxicol; 2000 Oct; 24(7):595-601. PubMed ID: 11043665
[TBL] [Abstract][Full Text] [Related]
14. Paradoxical role of cytochrome P450 3A in the bioactivation and clinical effects of levo-alpha-acetylmethadol: importance of clinical investigations to validate in vitro drug metabolism studies.
Kharasch ED; Whittington D; Hoffer C; Krudys K; Craig K; Vicini P; Sheffels P; Lalovic B
Clin Pharmacokinet; 2005; 44(7):731-51. PubMed ID: 15966756
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of an Automated Reader and Color Interpretation-Based Immunoassays for Multiplexed Drug-of-Abuse Testing in Urine.
Kim SY; Kim H; Park Y; Lim J; Kim J; Koo SH; Kwon GC
J Anal Toxicol; 2017 Jun; 41(5):412-420. PubMed ID: 28201761
[TBL] [Abstract][Full Text] [Related]
16. Detection of drugs of abuse in exhaled breath from users following recovery from intoxication.
Beck O; Stephanson N; Sandqvist S; Franck J
J Anal Toxicol; 2012; 36(9):638-46. PubMed ID: 23045289
[TBL] [Abstract][Full Text] [Related]
17. Determination of ∆-9-Tetrahydrocannabinol (THC), 11-hydroxy-THC, 11-nor-9-carboxy-THC and Cannabidiol in Human Plasma using Gas Chromatography-Tandem Mass Spectrometry.
Andrenyak DM; Moody DE; Slawson MH; O'Leary DS; Haney M
J Anal Toxicol; 2017 May; 41(4):277-288. PubMed ID: 28069869
[TBL] [Abstract][Full Text] [Related]
18. Analysis of drugs of abuse in urine by gas chromatography/mass spectrometry: experience and application.
Karacić V; Skender L
Arh Hig Rada Toksikol; 2000 Dec; 51(4):389-400. PubMed ID: 11276966
[TBL] [Abstract][Full Text] [Related]
19. Comparison of concentrations of drugs between blood samples with and without fluoride additive-important findings for Δ
Wiedfeld C; Krueger J; Skopp G; Musshoff F
Int J Legal Med; 2019 Jan; 133(1):109-116. PubMed ID: 29453495
[TBL] [Abstract][Full Text] [Related]
20. Occurrence of drugs of abuse and benzodiazepines in river waters from the Madrid Region (Central Spain).
Mendoza A; López de Alda M; González-Alonso S; Mastroianni N; Barceló D; Valcárcel Y
Chemosphere; 2014 Jan; 95():247-55. PubMed ID: 24083902
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
